Table 2.
Donor 1 |
Donor 2 |
Donor 3 |
|||||
---|---|---|---|---|---|---|---|
DMF5b | GFP | WT1 TCR | GFP | WT1 TCR | GFP | WT1 TCR | |
media | 28 | 30 | 29 | 28 | 28 | 30 | 30 |
T2 + MART peptidec | 9980g | 37 | 37 | 34 | 29 | 52 | 40 |
T2 + WT1 peptidec | 56 | 35 | >20000 | 32 | >20000 | 45 | >20000 |
COS-A2 + MARTd | 4710 | 31 | 37 | 36 | 33 | 83 | 43 |
COS-A2 + WT1d | 27 | 31 | 11449 | 34 | 8482 | 77 | 7254 |
293 SP + A2/MARTe | 872 | 29 | 28 | 28 | 28 | 29 | 29 |
293 SP + A2/WT1e | 28 | 29 | 52 | 28 | 66 | 31 | 61 |
293 IP + A2/MARTf | 79 | 29 | 29 | 33 | 30 | 34 | 41 |
293 IP + A2/WT1f | 28 | 29 | 1963 | 32 | 3606 | 36 | 1947 |
PBL from 3 HLA-A*0201+ donors were transduced with retroviral particles encoding GFP as a negative control or with the WT1 reactive TCR (TRAV12-1*01; CDR3: CVVNTPPNTDKLIF; TRBV7-2*01; CDR3: CASTPFTSGSGWDEQFF). Transduced T cells were cocultured overnight with the indicated target cells, and IFNγ in coculture supernatants was measured by ELISA.
DMF5 is a MART-1 reactive T cell population included as a positive control for the transfections.
T2 cells were pre-loaded with 1 μg/ml of a control peptide from HBV with high binding affinity for HLA-A*0201 or WT1:126-134 ~1 hour prior to the coculture.
COS-7 cells stably expressing high levels of HLA-A*0201 by means of retroviral transduction and antibiotic selection were transiently transfected with GFP cDNA as a negative control or full-length WT1 cDNA ~24 hours prior to the coculture.
293 cells expressing components of the standard proteasome were transiently co-transfected with HLA-A*0201 cDNA and either full-length MART-1 or WT1 cDNA ~24 hours prior to the coculture.
293 cells expressing inducible subunits 1, 2, and 5 of the immunoproteasome were transiently co-transfected with HLA-A*0201 cDNA and either full-length MART-1 or WT1 cDNA ~24 hours prior to the coculture.
underlined values indicate IFNγ secretion >100 pg/ml and >2X background with any negative control target cell.